Lineage Cell Therapeutics
LCTX
#8903
Rank
NZ$0.17 B
Marketcap
$0.77
Share price
-6.12%
Change (1 day)
-59.16%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2024 (TTM): -NZ$35.91 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are NZ$9.49 Million. , an increase over its 2023 earnings that were of -NZ$41.36 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$35.91 Million-13.16%
2023 -NZ$41.36 Million9.83%
2022 -NZ$37.66 Million-54.24%
2021 -NZ$82.28 Million86.07%
2020 -NZ$44.22 Million-31.97%
2019 -NZ$65 Million-5.42%
2018 -NZ$68.73 Million1.1%
2017 -NZ$67.98 Million-31.06%
2016 -NZ$98.6 Million-10.38%
2015 -NZ$0.12 Billion29.69%
2014 -NZ$84.84 Million31.68%
2013 -NZ$64.43 Million
2011 -NZ$31.27 Million89.78%
2010 -NZ$16.48 Million206.06%
2009 -NZ$5.39 Million-0.58%
2008 -NZ$5.42 Million164.89%
2007 -NZ$2.05 Million-30.22%
2006 -NZ$2.93 Million
2002 -NZ$3.41 Million-41.04%
2001 -NZ$5.77 Million-32.04%
2000 -NZ$8.49 Million-11.85%
1999 -NZ$9.63 Million
1997 -NZ$6.19 Million12.12%
1996 -NZ$5.52 Million106.25%
1995 -NZ$2.68 Million-11.11%
1994 -NZ$3.01 Million50%
1993 -NZ$2.01 Million20%
1992 -NZ$1.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.24 Billion 565.31%๐Ÿ‡บ๐Ÿ‡ธ USA